Beclin1 and HMGB1 ameliorate the α-synuclein-mediated autophagy inhibition in PC12 cells

Diagnostic Pathology
Kaihua WangZhenzhen Chen

Abstract

Aberrant α-synuclein aggregation due to the deficiency of ubiquitin-proteasome or of autophagy characterizes the parkinson disease (PD). High mobility group box 1 (HMGB1) is a novel stress sensor to mediate the persistent neuro-inflammation and the consequent progressive neurodegeneration, via controlling the cellular autophagy/apoptosis checkpoint during inflammation. Moreover, HMGB1 has been recently indicated to involve in the autophagic degradation of α-synuclein. In the current study, we investigated the influence of the overexpressed α-synuclein of wild type (wt) or mutant type (A53T and A30P, mt) on the cytosolic levels of HMGB1 and Beclin1 and on the starvation-induced autophagy in pheochromocytoma PC12 cells. And then we explored the overexpression of HMGB1 or of Beclin1 on the α-synuclein degradation and on the autophagy in the α-synuclein-overexpressed PC12 cells. It was demonstrated that α-synuclein overexpression inhibited the trans-location of HMGB1 from nucleus to cytosol and reduced the cytosolic level of Beclin1 in PC12 cells, and inhibited the starvation-induced autophagy via downregulating autophagy-associated markers and via reducing the autophagic vesicles in PC12 cells under starvation. On the other side, ...Continue Reading

References

May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
Jul 10, 1999·Science·H WangK J Tracey
Oct 25, 2007·Biochemical Society Transactions·M L Block, J-S Hong
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·John J ShackaJianhua Zhang
Jan 12, 2008·Brain : a Journal of Neurology·Tianhong PanJoseph Jankovic
Apr 24, 2008·Molecular Medicine·John R KluneAllan Tsung
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Jun 28, 2008·Parkinsonism & Related Disorders·Michela FerrucciFrancesco Fornai
Mar 20, 2009·Lancet Neurology·Etienne C Hirsch, Stéphane Hunot
Oct 30, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Brian SpencerEliezer Masliah
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Serge Przedborski
Mar 3, 2010·Annual Review of Immunology·Gary P SimsAnthony J Coyle
Sep 8, 2010·The Journal of Cell Biology·Daolin TangMichael T Lotze
Oct 12, 2010·Autophagy·Rui KangDaolin Tang
Oct 21, 2010·Physiological Reviews·Brinda RavikumarDavid C Rubinsztein
Dec 16, 2010·Autophagy·Ashley R Winslow, David C Rubinsztein
Jan 21, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hui-Ming GaoJau-Shyong Hong
Nov 22, 2011·Cancer Research·Jun HuangDaolin Tang
Mar 20, 2012·Neurobiology of Disease·Kristen A Malkus, Harry Ischiropoulos
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Casey CookLeonard Petrucelli
Jun 1, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lauren G FriedmanZhenyu Yue
Jun 30, 2012·Acta Neuropathologica·Darius Ebrahimi-FakhariPamela J McLean
Oct 27, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nicoletta Plotegher, Laura Civiero
Apr 24, 2013·Proceedings of the National Academy of Sciences of the United States of America·Mickael DecressacAnders Björklund
Oct 22, 2013·Nature Medicine·Yasuhiro MaejimaJunichi Sadoshima
Nov 8, 2013·Cancer Research·Yi LuoHiroki Kuniyasu
Feb 14, 2014·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Lei-Lei ChenMin Li
Aug 16, 2014·Autophagy·Xiaofang Sun, Daolin Tang
Sep 11, 2014·International Journal of Molecular Sciences·Guobin LiPeng Lun
Feb 3, 2015·The Journal of Clinical Investigation·Xiaorong ZhuEugene B Chang
May 2, 2015·The Journal of Biological Chemistry·Christopher C PanNam Y Lee
Aug 21, 2015·Nature Communications·Kevin MoreauDavid C Rubinsztein
Aug 28, 2015·Nature Communications·Pui-Mun WongXuejun Jiang

❮ Previous
Next ❯

Citations

May 2, 2017·Annual Review of Biochemistry·Ivan Dikic
Jan 27, 2017·Molecular Neurodegeneration·Tim E MoorsWilma D J van de Berg
Jan 10, 2018·Neurotoxicity Research·Juan Segura-Aguilar
Feb 28, 2018·Current Medicinal Chemistry·Silvia Cerri, Fabio Blandini
Mar 7, 2020·Biomolecules·Margaux TeilBenjamin Dehay
Feb 16, 2017·Frontiers in Molecular Neuroscience·Jinsha HuangTao Wang
May 3, 2018·Frontiers in Aging Neuroscience·Xian-Si ZengPeng-Peng Zhang
Feb 13, 2019·International Journal of Molecular Sciences·Michiel Van BulckJose A Morales-Garcia
May 28, 2019·Frontiers in Neuroscience·Šárka LehtonenJari Koistinaho
Jun 12, 2019·Cells·Marie-Laure ArotcarenaBenjamin Dehay
Dec 17, 2020·Cells·Masahiro NishiboriHidenori Wake
Jul 27, 2021·Frontiers in Aging Neuroscience·Upasana GangulySasanka Chakrabarti
Nov 20, 2021·Cellular and Molecular Neurobiology·Yu TianZhaoliang Su

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence
transfection
PCR
fluorescence microscopy

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.